Menu

Home / For Visitors / Exhibitor Product / Chimeric Antigen Receptor T Cell, CAR.BiTE γδT (CAR001)

Chimeric Antigen Receptor T Cell, CAR.BiTE γδT (CAR001)

Model: CAR001)

Category: Pharmaceutical

Exhibitor: EVER SUPREME BIO TECHNOLOGY CO., LTD.

Booth No: N114

Characteristic

CAR001 is an innovative allogeneic CAR.BiTE γδT cell therapy with a dual-target design. It targets two major immunosuppressive tumor antigens, HLA-G and PD-L1, and combines chimeric antigen receptor (CAR) and bispecific T cell conjugate (BiTE) to simultaneously identify tumor cells and activate endogenous T cells, which can significantly improve the targeting and killing effect on solid tumors.

Other Products

CAR.BiTE@CD3e-Nb EV (EXO001)

Products you may be interested in

Highest Rated Products

TOP